Lighting the way to targeted therapies and fewer side effects

April 4, 2018, American Chemical Society

Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early. But according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, researchers are developing strategies to reduce side effects by turning drugs on and off with light in specific locations, such as a tumor.

Contributing Editor Katharine Sanderson points out that using light to treat disease isn't new, but so far, it's typically been applied to skin conditions. For example, with , doctors shine light onto the skin to activate a dye in the affected area. The activated dye turns oxygen to a toxic singlet form that kills . But in some conditions, such as cancer, affected tissues can be starved of oxygen, potentially reducing the chances that this approach will work.

Now, scientists are developing photoswitchable therapies that take energy from a photon of light to change their structure and treat disease. The therapies aim to go deeper, turning on to kill tumors and turning on antibiotics to wipe out bacteria within the body. But the field faces challenges. Some therapies are switched on with UV light, but these wavelengths don't penetrate very far through the skin and can cause mutations. Red and infrared can go deeper, but they could have less energy, resulting in a drug that is not very potent. Obtaining regulatory approvals also could be complicated, as one drug could be thought of as two different ones because it would have an "on" and an "off" state. Despite these issues, researchers are moving forward, shining a path toward more selective therapies.

Explore further: Tuning light to kill deep cancer tumors

More information: "Photoswitchable drugs could light the way to more targeted treatments," … ht-way-targeted.html

Related Stories

Tuning light to kill deep cancer tumors

October 15, 2014

An international group of scientists led by Gang Han, PhD, at the University of Massachusetts Medical School, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set ...

Counting cancer-busting oxygen molecules

February 5, 2016

Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep ...

Light-activated cancer drugs without toxic side effects

February 13, 2018

Future cancer drugs that are activated by light and don't cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research made possible by the Monash Warwick Alliance, ...

Recommended for you

3-D culturing hepatocytes on a liver-on-a-chip device

January 17, 2019

Liver-on-a-chip cell culture devices are attractive biomimetic models in drug discovery, toxicology and tissue engineering research. To maintain specific liver cell functions on a chip in the lab, adequate cell types and ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.